Health Canada Advises Not To Use Soloslim For Weight Loss
Health Canada is advising consumers not to use Soloslim due to concerns about possible side-effects.
Product Description: Soloslim is promoted as an "all natural" product used for weight loss.
Reason for Warning: The Hong Kong Department of Health warned against the use of Soloslim because it was found to contain an undeclared compound similar in structure to sibutramine (N-bisdesmethyl-sibutramine). Sibutramine is a prescription drug used in the treatment of obesity.
Soloslim also contains L-carnitine salt. L-carnitine is a prescription drug used in the treatment of carnitine deficiency, which may occur in patients with some genetic diseases, serious liver or kidney disease or with use of certain medications (e.g. valproate).
Both sibutramine and L-carnitine should only be used under the supervision of a health care professional.
Soloslim also contains synephrine. Weight loss products containing synephrine are not authorized for sale in Canada.
Possible Side-Effects: Use of sibutramine may cause headaches, increased heart rate and blood pressure, chest pain and stroke.
Side-effects associated with L-carnitine include nausea, vomiting, abdominal cramps, diarrhea and seizures.
Synephrine may cause cardiovascular adverse effects that could lead to stroke, heart attack and/or death.